The effect of naproxen on the healing process of patients with COVID-19
Phase 3
Completed
- Conditions
- corona virus disease.COVID-19, virus not identifiedU07.2
- Registration Number
- IRCT20200324046850N3
- Lead Sponsor
- Abadan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
COVID-19 patients that have positive PCR test of nasopharyngeal sample or have positive CT Scan
Having consent to participate in the intervention
Exclusion Criteria
pregnant or breast feeding women
Those taking losartan and captopril.
Those with a history of intestinal ulcers or gastrointestinal bleeding.
Children under 14 years
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time to clinical improvement defined as start of taking medication time to the next 28 days. Timepoint: The beginning of the study ,the seventh day, the fourteenth day, the twenty-first day, the twenty-eighth day. Method of measurement: Medical record.
- Secondary Outcome Measures
Name Time Method